NATCO Pharma Competitors and Similar CompaniesClear all

NATCO Pharma's competitors and similar companies include Syngene International, Siegfried, Pharmstandard and CHUGAI PHARMA FRANCE.
NATCO Pharma
NATCO Pharma
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
Syngene International
Syngene International
Syngene International is integrated research, development, and manufacturing company providing scientific services.
Siegfried
Siegfried
Siegfried Holding is a company that develops and manufactures drug substances and products.
Pharmstandard
Pharmstandard
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
CHUGAI PHARMA FRANCE
CHUGAI PHARMA FRANCE
CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
Founding Date
Founding Date
1981
Founding Date
1993
Founding Date
1873
Founding Date
2003
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
Hyderabad, IN HQ
Central Hope Town, IN
Chennai, IN
Hyderabad, IN
Santola, IN
Vijayapuri North, IN
Locations
Bangalore, IN HQ
Bangalore, IN
Bengaluru, IN
Locations
Zofingen, CH HQ
Nantong, CN
Saint Vulbas, FR
Hameln, DE
Minden, DE
Birżebbuġa, MT
Barberà Del Vallès, ES
see more
Locations
Dolgoprudny, RU HQ
Kursk, RU
Moscow, RU
Tomsk, RU
Ufa, RU
Locations
Paris, FR HQ
Employees
Employees
3,946
Employees
6,5105% decrease
Employees
3,819
Employees
1,56135% increase
Employees
7517% decrease

Financial

Revenue (est.)
Revenue (est.)
₹40b (FY, 2024)
Revenue (est.)
₹33.7b (FY, 2024)
Revenue (est.)
CHF1.3b (FY, 2023)
Revenue (est.)
₽142.9b (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
₹7.2b (FY, 2024)
Cost of goods
₹9.3b (FY, 2024)
Cost of goods
CHF869.7m (FY, 2023)
Cost of goods
₽109.3b (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
₹34.1b (FY, 2024)
Gross profit
₹25.6b (FY, 2024)
Gross profit
CHF406.7m (FY, 2023)
Gross profit
₽33.6b (FY, 2023)
Gross profit
N/A
Net income
Net income
₹13.9b (FY, 2024)
Net income
₹5.1b (FY, 2024)
Net income
CHF112.7m (FY, 2023)
Net income
₽23.3b (FY, 2023)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Syngene International
HQ
Bangalore, IN
Employees
6,510↓ 5% decrease

Syngene International is integrated research, development, and manufacturing company providing scientific services.

View company
Siegfried
HQ
Zofingen, CH
Employees
3,819

Siegfried Holding is a company that develops and manufactures drug substances and products.

View company
Pharmstandard
HQ
Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

View company
CHUGAI PHARMA FRANCE
HQ
Paris, FR

CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.

View company